Financial News
Single-cell Technologies Research Report 2023-2024 & 2029 10x Genomics, Agilent Technologies, BD, Bio-Rad Laboratories, Danaher, Illumina, Merck, Promega, Qiagen, & Thermo Fisher Scientific - ResearchAndMarkets.com
The "Single-cell Technologies Market Report" has been added to ResearchAndMarkets.com's offering.
The global market for single-cell technologies is estimated to increase from $3.6 billion in 2023 to reach $9.2 billion by 2029, at a compound annual growth rate (CAGR) of 17.1% from 2024 through 2029.
The report offers comprehensive insights into the global single-cell technologies market. It includes 33 data tables and 48 additional tables that present detailed market data and analysis. The report delves into global market trends, providing historical revenue data for 2022-2023, estimates for 2024, and projections through 2029, including Compound Annual Growth Rates (CAGR). This analysis covers various market segments such as product type, techniques, cell type, application, end user, and region, offering a thorough understanding of revenue prospects and market share distribution.
Key growth drivers and market restraints are explored, with facts and figures addressing the forces shaping the market. Additionally, the regulatory landscape is examined to provide insight into how current regulations may impact market dynamics. The report also includes a detailed analysis of patent trends related to single-cell technologies, highlighting innovation and intellectual property developments within the industry.
In terms of sustainability, the report offers an overview of Environmental, Social, and Governance (ESG) trends, focusing on consumer attitudes, ESG scores, and corporate sustainability practices. This information is crucial for understanding the growing importance of ESG considerations in corporate strategies and operations.
Finally, the report features in-depth profiles of key industry players such as 10x Genomics, BD, and Thermo Fisher Scientific Inc. These profiles provide insights into the strategies and market positions of major companies, offering valuable guidance for stakeholders looking to navigate the competitive landscape of the single-cell technologies market.
The market is segmented by product into consumables and instruments. By cell type, it is classified into human cells, animal cells and microbial cells. By techniques, it encompasses flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry, and other techniques. By application, it is segmented into research applications and medical applications.
Also, by end user, it is categorized into research and academic laboratories, biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, and cell banks and IVF centers.
Key Attributes:
Report Attribute | Details |
No. of Pages | 112 |
Forecast Period | 2024 - 2029 |
Estimated Market Value (USD) in 2024 | $3.6 Billion |
Forecasted Market Value (USD) by 2029 | $9.2 Billion |
Compound Annual Growth Rate | 17.1% |
Regions Covered | Global |
Company Profiles
- 10x Genomics
- Agilent Technologies Inc.
- BD
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- Illumina Inc.
- Merck KGAA
- Promega Corp.
- Qiagen
- Thermo Fisher Scientific Inc.
Key Topics Covered:
Chapter 1: Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2: Market Overview
- Bulk vs. Single-Cell Sequencing
- PESTLE Analysis
- Porter's Five Forces Analysis
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential of New Entrants
- Competition in the Industry
- Threat of Substitutes
Chapter 3: Market Dynamics
Market Drivers
- Rising Incidence of Cancer
- Growing Demand for Personalized Medicine
- Increasing Investment and Funding
Market Restraints
- High Cost of Single-Cell Analysis
Market Opportunities
- Emerging Economies
Market Challenges
- Complexity of Single-Cell Sequencing
Chapter 4: Emerging Technologies and Developments
- Emerging Technologies
- Advances in Bioinformatics
- Microfluidics
- Artificial Intelligence
- Clinical Trials Analysis
- Clinical Trials Analysis, by Type of Study
- Clinical Trials Analysis, by Status
- Clinical Trials Analysis, by Phase
- Selected Clinical Trials
- Patent Analysis
- Patents by Year
- Patents by Top Applicants
- Patents by Top Owner
- Patents by Jurisdiction
Chapter 5: Market Segmentation Analysis
Market Analysis by Product
- Consumables
- Instruments
Market Breakdown by Cell Type
- Human Cells
- Animal Cells
- Microbial Cells
Market Breakdown by Technique
- Flow Cytometry
- Next-Generation Sequencing
- Polymerase Chain Reaction
- Microscopy
- Mass Spectrometry
- Other Techniques
Market Breakdown by Application
- Research Applications
- Medical Applications
Market Breakdown by End User
- Research and Academic Laboratories
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Cell Banks and IVF Centers
Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6: Competitive Intelligence
- Market Analysis
- Top Players
- Emerging Startups
- Strategic Analysis
Chapter 7: Sustainability in Single-cell Technologies: An ESG Perspective
- Introduction to ESG
- Sustainability in Single-Cell Technologies Industry: An ESG Perspective
- Key ESG Issues
- Single-Cell Technologies ESG Performance Analysis
- Concluding Remarks from BCC
Chapter 8: Appendix
For more information about this report visit https://www.researchandmarkets.com/r/ahb55g
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241011348553/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.